Page 20 - 91307c10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pinebridge Investments L.P. raised its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 29.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 7,967 shares of the biotechnology company’s stock after purchasing an additional 1,808 shares during the quarter. Pinebridge Investments L.P.’s holdings in United Therapeutics were worth $2,216,000 as […]

United Therapeutics Co. (NASDAQ:UTHR – Get Rating) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to […]

Financial Enhancement Group LLC raised its stake in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 1.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,049 shares of the biotechnology company’s stock after acquiring an additional 279 shares during the period. […]

Oak Associates Ltd. OH cut its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 35.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,006 shares of the biotechnology company’s stock after selling 6,054 shares during the period. Oak Associates Ltd. […]

United Therapeutics Co. (NASDAQ:UTHR – Get Rating) Director Nilda Mesa sold 374 shares of United Therapeutics stock in a transaction that occurred on Friday, May 5th. The shares were sold at an average price of $214.81, for a total transaction of $80,338.94. Following the sale, the director now directly owns 5,806 shares of the company’s […]